Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study
Crossref DOI link: https://doi.org/10.1186/s12890-021-01559-7
Published Online: 2021-06-08
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huang, Tang-Hsiu
Kuo, Chin-Wei
Chen, Chian-Wei
Tseng, Yau-Lin
Wu, Chao-Liang
Lin, Sheng-Hsiang
Text and Data Mining valid from 2021-06-08
Version of Record valid from 2021-06-08
Article History
First Online: 8 June 2021